RYANODEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ryanodex, and when can generic versions of Ryanodex launch?
Ryanodex is a drug marketed by Eagle Pharms and is included in one NDA. There is one patent protecting this drug.
This drug has eight patent family members in five countries.
The generic ingredient in RYANODEX is dantrolene sodium. There are five drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the dantrolene sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ryanodex
A generic version of RYANODEX was approved as dantrolene sodium by IMPAX LABS on March 1st, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for RYANODEX?
- What are the global sales for RYANODEX?
- What is Average Wholesale Price for RYANODEX?
Summary for RYANODEX
International Patents: | 8 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 125 |
Clinical Trials: | 3 |
Patent Applications: | 2,760 |
Drug Prices: | Drug price information for RYANODEX |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for RYANODEX |
What excipients (inactive ingredients) are in RYANODEX? | RYANODEX excipients list |
DailyMed Link: | RYANODEX at DailyMed |
Recent Clinical Trials for RYANODEX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Eagle Pharmaceuticals, Inc. | Phase 3 |
Quintiles, Inc. | Phase 2 |
Eagle Pharmaceuticals, Inc. | Phase 2 |
Pharmacology for RYANODEX
Drug Class | Skeletal Muscle Relaxant |
Physiological Effect | Decreased Striated Muscle Contraction Decreased Striated Muscle Tone |
US Patents and Regulatory Information for RYANODEX
RYANODEX is protected by one US patents.
Patents protecting RYANODEX
Treatment using dantrolene
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eagle Pharms | RYANODEX | dantrolene sodium | FOR SUSPENSION;INTRAVENOUS | 205579-001 | Jul 22, 2014 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for RYANODEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Eagle Pharms | RYANODEX | dantrolene sodium | FOR SUSPENSION;INTRAVENOUS | 205579-001 | Jul 22, 2014 | ⤷ Sign Up | ⤷ Sign Up |
Eagle Pharms | RYANODEX | dantrolene sodium | FOR SUSPENSION;INTRAVENOUS | 205579-001 | Jul 22, 2014 | ⤷ Sign Up | ⤷ Sign Up |
Eagle Pharms | RYANODEX | dantrolene sodium | FOR SUSPENSION;INTRAVENOUS | 205579-001 | Jul 22, 2014 | ⤷ Sign Up | ⤷ Sign Up |
Eagle Pharms | RYANODEX | dantrolene sodium | FOR SUSPENSION;INTRAVENOUS | 205579-001 | Jul 22, 2014 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for RYANODEX
See the table below for patents covering RYANODEX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
World Intellectual Property Organization (WIPO) | 2005013919 | ⤷ Sign Up | |
European Patent Office | 1435781 | ⤷ Sign Up | |
World Intellectual Property Organization (WIPO) | 03000057 | ⤷ Sign Up | |
Canada | 2516667 | TRAITEMENT AU MOYEN DE DANTROLENE (TREATMENT USING DANTROLENE) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |